Latest Leverage News

Sovereign Metals has delivered a definitive feasibility study (DFS) for its Kasiya Rutile-Graphite Project in Malawi, revealing robust economics, a 25-year mine life, and the potential to become the world’s largest producer of natural rutile and flake graphite, both critical minerals for Western supply chains.

Aquirian’s Drillforce subsidiary has secured a $48 million, three-year drilling and blasting contract at Brightstar’s Lord Byron mine, marking a significant expansion of their strategic partnership in Western Australia’s Goldfields region.

Brightstar Resources has secured a five-year strategic agreement with Aquirian Limited to supply drill and blast services at its Goldfields Hub, leveraging patented technology to optimise open pit mining efficiency and safety.

Noronex completed maiden drilling programs at key uranium and copper projects while bolstering its cash position through strategic asset sales. The company also formalised a 51% stake in its Etango North uranium project and navigates a CEO transition.

Temas Resources is tapping the Canadian market with a $1.5 million flow-through share placement aimed at advancing its titanium projects in Quebec. The raise supports exploration expenses tied to its proprietary processing technology and resource development.

Desert Metals Limited has launched a fully underwritten entitlement offer to raise approximately $325,000 through new options, aiming to fund ongoing exploration at its gold prospects in Côte d’Ivoire.

Fat Prophets Global Contrarian Fund (ASX: FPC) has disclosed the Dividend Reinvestment Plan (DRP) price for its six-month dividend ending December 2025, applying a 2.5% discount to the volume weighted average price, resulting in a DRP price of AUD 1.35 per share.

Marquee Resources (ASX:MQR) has secured a non-exclusive R&D patent licence with Oak Ridge National Laboratory, granting access to NEAREST technology tailored for clay-rich rare earth deposits like Redlings in WA. This partnership could reshape processing efficiency and environmental impact for Marquee’s significant inferred resource.

Omnia Metals has made a decisive entry into the US critical minerals market by acquiring the Stibnite Ridge antimony and silver project and staking the Radix rare earth and gallium project in Montana, backed by a $1.5 million capital raise.

Charger Metals has confirmed significant extensions to spodumene mineralisation at its Medcalf project, with drilling pushing lithium-bearing pegmatites to 600-700m depth and along strike. The company anticipates a substantial resource upgrade following assay results due in the coming weeks.

Noxopharm appoints its Chief Scientific Officer Dr Olivier Laczka as CEO, aiming to capitalise on recent clinical successes and expand the Sofra™ technology’s reach in autoimmune and oncology markets.

Immutep Limited has won FDA Orphan Drug Designation for its immunotherapy eftilagimod alfa in treating soft tissue sarcoma, opening regulatory incentives and potential market exclusivity. This follows encouraging Phase II data despite recent Phase III trial setbacks.